Fundamental Analysis
33 / 100BRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | -66.4% | -42.4% | 1 / 3 | -56.3% | +0.56 pp | -0.42 pp | +6.2% | 0.68 | 6.93 | 228 | −56,3% | 3,2 | −66,4% | 6.93 | 8.15 | −14,9% |
| Pts | 0 | 0 | 4 | 0 | 8 | 4 | 0 | 12 | 8 | |||||||
Valuation annotation:Price: 6.500 (close price on 2026-09-23)EPS (TTM): 937,5
Financial charts
1.Revenue & growth
VND bn228Q2/26
1.Revenue & growth
VND bn228Q2/26
2.Profit & growth
VND bn3,14Q2/26
3.Profit mix (Penman)
VND bn15,6Q2/26
4.Margins & cost structure
%10.1%Q2/26
5.Returns & cash cycle
% · days5.3%Q2/26
6.Earnings quality & cash
VND bn166Q2/26
7.Asset structure
VND bn497Q2/26
8.Funding & debt health
VND bn · times497Q2/26
9.Revenue backlog
VND bn7,00Q2/26
10.Valuation
times · %7,0×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %245Q2/26
Adjusted EPS growth, latest quarter
-67.0%
Average adjusted EPS growth, 3 quarters
-42.6%
Quarters at 25%+ growth
1/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26